[Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants]

Pediatr Pol. 1981 Oct;56(10):1243-8.
[Article in Polish]
No abstract available

MeSH terms

  • Alprostadil
  • Heart Defects, Congenital / drug therapy*
  • Humans
  • Hypoxia / drug therapy
  • Infant
  • Infant, Newborn
  • Prostaglandins E / therapeutic use*
  • Prostaglandins E, Synthetic / therapeutic use*
  • Pulmonary Artery / abnormalities
  • Transposition of Great Vessels / drug therapy

Substances

  • Prostaglandins E
  • Prostaglandins E, Synthetic
  • Alprostadil